Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized, controlled trials
- PMID: 19643407
- DOI: 10.1016/j.gie.2009.02.029
Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized, controlled trials
Abstract
Background: Previous clinical trials on the treatment of esophageal variceal bleeding yielded mixed results regarding the efficacy of endoscopic procedures compared with pharmacotherapy only.
Objective: To compare the efficacy of endoscopic procedures with that of pharmacotherapy in the prevention of mortality and rebleeding.
Design and setting: A systematic literature review was performed to identify randomized, controlled trials of the efficacy of pharmacotherapy and endoscopic therapy. A meta-analysis was performed by using the Comprehensive MetaAnalysis software package. A 2-sided alpha error <.05 was considered statistically significant (P < .05).
Patients: Twenty-five clinical trials with a total of 2159 patients were eligible for meta-analysis.
Outcome measurements: Relative risk (RR) with 95% confidence interval (CI) was computed for all-cause mortality, mortality from rebleeding, all-cause rebleeding, and rebleeding caused by varices.
Results: Pharmacotherapy was as effective as endoscopic procedures in preventing rebleeding (RR 1.067; 95% CI, 0.865-1.316; P = .546), variceal rebleeding (RR 1.143; 95% CI, 0.791-1.651; P = .476), all-cause mortality (RR 0.997; 95% CI, 0.827-1.202, P = .978), and mortality from rebleeding (RR 1.171; 95% CI, 0.816-1.679; P = .39). Pharmacotherapy combined with endoscopic procedures did not reduce all-cause mortality (RR 0.787; 95% CI, 0.587-1.054; P = .108) or mortality caused by rebleeding (RR 0.786; 95% CI, 0.445-1.387; P = .405) compared with endoscopic procedures. However, combination therapy (endoscopic procedure plus pharmacotherapy) significantly reduced the incidence of all rebleeding (RR 0.623; 95% CI, 0.523-0.741; P < .001) and variceal rebleeding (RR 0.601; 95% CI, 0.440-0.820; P < .001).
Limitations: Heterogeneity of patient population and different treatment protocols may have affected our meta-analysis.
Conclusion: Pharmacotherapy may be as effective as endoscopic therapy in reducing rebleeding rates and all-cause mortality. Pharmacotherapy plus endoscopic intervention is more effective than endoscopic intervention alone.
Comment in
-
Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding.Gastrointest Endosc. 2009 Oct;70(4):665-7. doi: 10.1016/j.gie.2009.05.035. Gastrointest Endosc. 2009. PMID: 19788982 No abstract available.
-
Combination of pharmacologic and endoscopic therapy for preventing variceal rebleeding.Gastrointest Endosc. 2010 Aug;72(2):465. doi: 10.1016/j.gie.2009.11.009. Gastrointest Endosc. 2010. PMID: 20674633 No abstract available.
Similar articles
-
Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis.Ann Intern Med. 2008 Jul 15;149(2):109-22. doi: 10.7326/0003-4819-149-2-200807150-00007. Ann Intern Med. 2008. PMID: 18626050
-
Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: a meta-analysis.World J Gastroenterol. 2015 Feb 28;21(8):2534-41. doi: 10.3748/wjg.v21.i8.2534. World J Gastroenterol. 2015. PMID: 25741164 Free PMC article. Review.
-
Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices.Aliment Pharmacol Ther. 2012 May;35(10):1155-65. doi: 10.1111/j.1365-2036.2012.05074.x. Epub 2012 Mar 26. Aliment Pharmacol Ther. 2012. PMID: 22449261
-
Prevention of variceal rebleeding.Gastroenterol Clin North Am. 1992 Mar;21(1):119-47. Gastroenterol Clin North Am. 1992. PMID: 1349003 Review.
-
Pharmacotherapy alone vs endoscopic variceal ligation combination for secondary prevention of oesophageal variceal bleeding: meta-analysis.Liver Int. 2012 May;32(5):867-9. doi: 10.1111/j.1478-3231.2011.02681.x. Epub 2011 Dec 2. Liver Int. 2012. PMID: 22133043 No abstract available.
Cited by
-
Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence.Ther Adv Chronic Dis. 2019 Jul 12;10:2040622319862693. doi: 10.1177/2040622319862693. eCollection 2019. Ther Adv Chronic Dis. 2019. PMID: 31321015 Free PMC article. Review.
-
Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.Oncotarget. 2017 May 24;8(34):57399-57408. doi: 10.18632/oncotarget.18143. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915680 Free PMC article.
-
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis.World J Gastroenterol. 2010 Dec 21;16(47):5982-92. doi: 10.3748/wjg.v16.i47.5982. World J Gastroenterol. 2010. PMID: 21157975 Free PMC article.
-
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.Clin Mol Hepatol. 2020 Apr;26(2):83-127. doi: 10.3350/cmh.2019.0010n. Epub 2020 Jan 10. Clin Mol Hepatol. 2020. PMID: 31918536 Free PMC article. No abstract available.
-
Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.Hepatol Int. 2019 Jul;13(4):468-481. doi: 10.1007/s12072-019-09951-6. Epub 2019 Jun 7. Hepatol Int. 2019. PMID: 31175581
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical